Accolade, Inc.

NasdaqGS ACCD

Accolade, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending November 30, 2024: USD 6.22 M

Accolade, Inc. Net Cash Used Provided By Financing Activities is USD 6.22 M for the Trailing 12 Months (TTM) ending November 30, 2024, a 110.69% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Accolade, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending November 30, 2023 was USD -58.15 M, a -1,170.56% change year over year.
  • Accolade, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending November 30, 2022 was USD 5.43 M, a -97.91% change year over year.
  • Accolade, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending November 30, 2021 was USD 260.29 M, a -39.18% change year over year.
  • Accolade, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending November 30, 2020 was USD 427.95 M, a 1,691.65% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
NasdaqGS: ACCD

Accolade, Inc.

Description

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Similar companies

PRVA

Privia Health Group, Inc.

USD 22.85

1.38%

EVH

Evolent Health, Inc.

USD 10.45

-1.23%

NRC

National Research Corporation

USD 16.67

-0.30%

CERT

Certara, Inc.

USD 14.23

1.64%

DH

Definitive Healthcare Corp.

USD 4.86

-1.22%

PHR

Phreesia, Inc.

USD 28.46

-1.86%

HSTM

HealthStream, Inc.

USD 32.65

-0.52%

HCAT

Health Catalyst, Inc.

USD 5.63

1.99%

PINC

Premier, Inc.

USD 22.66

-1.48%

StockViz Staff

February 3, 2025

Any question? Send us an email